Recombinant Bordetella pertussis brkA Protein，His & Myc

The BrkA protein, derived from the pathogenic bacterium *Brucella spp.*, plays a crucial role in the organism's virulence and immune evasion mechanisms. As a member of the ATP-binding cassette (ABC) transporter family, BrkA is implicated in the intracellular survival of *Brucella*, enabling it to evade host immune responses and replicate within host cells. Research into BrkA has garnered significant attention due to its potential as a target for vaccine development and treatment strategies against brucellosis, a zoonotic disease affecting both livestock and humans. Understanding the structure and function of BrkA through recombinant protein expression can provide insights into its role in pathogenesis and help identify potential therapeutic interventions. Previous studies have shown that BrkA can modulate host cell signaling pathways, emphasizing its significance in the bacteria's ability to manipulate the host environment for survival. Additionally, the production of recombinant BrkA protein allows for the examination of antibody responses in vaccinated animals, thus aiding in the development of diagnostic tools and vaccines. Overall, research on BrkA not only enhances our understanding of *Brucella* biology but also contributes to broader efforts in infectious disease control and prevention.